Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bioequivalence Studies of Dasatinib 100 Mg
Sponsor: Centro de Atencion e Investigacion Medica
Summary
A bioequivalence study of Dasatinib will be carried out in 46 healthy subjects, in fed condition, following the complete replicated design, randomized, comparative of 2 sequences, 2 study formulations, in a single dose of 100 mg of Dasatinib tablets / coated tablets, 4 periods. , with a washout time of 7 days between each dose
Official title: Bioequivalence Studies of Dasatinib 100 Mg Tablets in Healthy Colombian Subjects in Postprandial Condition
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2025-09-01
Completion Date
2026-04-30
Last Updated
2025-02-12
Healthy Volunteers
Yes
Conditions
Interventions
Dasatinib 100 MG
single dose of 100 mg Dasatinib tablets
Locations (1)
CAIMED
Chía, Cundinamarca, Colombia